InvestorsHub Logo
Followers 231
Posts 34993
Boards Moderated 1
Alias Born 11/19/2003

Re: Milarepa post# 2822

Saturday, 08/25/2018 9:08:30 AM

Saturday, August 25, 2018 9:08:30 AM

Post# of 3057
I received this email from Elysium,

disclosure: I'm a Chromadex NR subscriber.

Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

https://www.elysiumhealth.com/en-us/knowledge/press/elysium-health-announces-exclusive-license-for-use-of-nicotinamide-riboside-for-the-slowing-of-aging-and-prevention-of-age-related-diseases-from-mayo-clinic-and-harvard?utm_source=email-batch&utm_medium=newsletter&utm_campaign=august-newsletter
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDXC News